Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Intensive care room with ventilator (right). Photo: Ronald Bonss/picture alliance via Getty Images

Automakers and their parts suppliers are offering to produce desperately needed ventilators to keep coronavirus patients alive, but quickly retooling industrial factories to make precision medical equipment might not be feasible, despite the good intentions.

Why it matters: The U.S. faces a critical shortage of medical equipment to fight the disease, including ventilators that help patients breathe as well as protective gear, such as masks, gloves and gowns, for health care workers.

The big picture: The auto industry has virtually shut down in North America for deep factory cleanings, and if and when they'll resume production isn't clear.

  • Unionized auto workers at GM, Ford and Fiat Chrysler are worried about contracting the virus on the assembly line and are working with the companies to restructure work shifts to mitigate the risk.

Driving the news: In a call Wednesday to inform the Trump Administration of the shutdown, GM CEO Mary Barra told White House Economic Adviser Larry Kudlow that GM wanted to help and was studying how it could potentially support production of medical equipment like ventilators.

  • That news prompted a similar statement from Ford, and later, Tesla CEO Elon Musk tweeted, "We will make ventilators if there is a shortage."

What's happening: The Toronto-based Automotive Parts Manufacturers' Association is enlisting tool and die companies and parts suppliers to adapt their manufacturing plants on both sides of the border to produce medical supplies.

  • "Their response has been overwhelming ... Just get us the specs," APMA President Flavio Volpe told the CBC.
  • The shift to medical supplies would be easy enough to do, he said, and they could convert back to automotive manufacturing quickly.

Yes, but: Pivoting to wartime footing for ventilators is not like churning out tanks, planes and ships for World War II, says Sandy Munro, CEO of Munro & Associates, an expert in lean manufacturing who has intimate knowledge of both the auto and medical device industries.

  • Production of medical devices requires sterile rooms with much higher standards than those required in a "clean room" at an automotive paint shop, for example, he says.
  • The Food and Drug Administration would have to validate any new facilities, a process that can take up to 180 days, explains The Huffington Post.
  • The technicians who manufacture ventilators also require eight to nine months' training, says Munro.
  • "Medical devices are intricate machines on which people’s lives depend. Every step of the production process has to be precise. This isn’t just a box with an air hose on it."
  • Nor is it clear that auto workers who were afraid of infection making auto parts would feel any safer going back to produce ventilators.

One of the biggest challenges is securing components, especially the disposable, single-use tubes and masks made of highly specialized medical-grade materials, experts say.

  • Most are manufactured outside the U.S. — in Costa Rica, Japan, South Korea and China, says Munro.
  • The virus has slowed production in many parts of the world, and even where factories are producing, shipping is complicated by a drastic reduction in cargo carriers and air freight.

What to watch: The federal government could clear many of these hurdles, especially if it activates the Defense Production Act, which would mobilize private industry to assist in "national defense."

  • It could provide federal help in the form of loans, faster regulatory and customs processes and even the chartering of planes and ships to deliver components more quickly.

Go deeper: At war with no ammo’: Doctors say shortage of protective gear is dire (NYT)

Go deeper

21 mins ago - Health

U.S. COVID-19 death toll surpasses 600,000

Expand chart
Data: Johns Hopkins University; Chart: Danielle Alberti/Axios

More than 600,000 people have died from the coronavirus in the U.S., according to data from Johns Hopkins University.

The big picture: It's a higher death toll than the number of American soldiers killed in combat during the Vietnam War, World War I and World War II combined.

Senate confirms antitrust expert Lina Khan as FTC commissioner

Lina Khan speaks at a Senate Commerce, Science and Transportation Committee confirmation hearing. Photographer: Saul Loeb/AFP/Bloomberg via Getty Images.

The Senate voted 69-28 on Tuesday to confirm antitrust expert Lina Khan as a commissioner on the Federal Trade Commission.

Why it matters: Known for her work on how to apply antitrust laws to the tech industry, Khan's confirmation marks a changing tide in federal government efforts to rein in Big Tech companies, Axios' Ashley Gold and Margaret Harding McGill report.